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Abstract:
This article discusses the author's experience in managing fibrous dysplasia of faciomaxillary 
region.  Data was accumulated from 2005 – 2011.  All these cases were managed by the author. 
Commonest bone involved by fibrous dysplasia was maxilla (Literature search did not reveal any 
female preponderance in monostotic fibrous dysplasia
15)In the author's series all of them were 
females.  All of them were monostotic fibrous dysplasia.
Introduction:
Fibrous dysplasia is a benign slow growing fibro-osseous disease characterised by replacement of 
normal bone with varying degrees of fibrous tissue / immature woven bone.  This was first 
described by Lichtenstein in 1938
1 who called it “perverted activity of bone forming mesenchyme”.
Classification of fibrous dysplasia
2 :
1. Monostotic variety – Involving single bone
2. Polyostotic variety – Involving multiple bones
3. McCune-Albright syndrome – Characterised by polyostotic fibrous dysplasia in assocaition 
with hyperfunctional endocrinopathies (precocious puberty, hyperthyroidism, or 
acromegaly) and cafe au lait spots involving the skin.
Epidemiology:
Classic epidemiological features of this disorder include:
1. It accounts for about 10% of all bony tumors
4
2. Monostotic variety is ten times more prevalent than polyostotic variety
3. Majority of monostotic fibrous dysplasia manifest during the first three decades of life
4. Polyostotic fibrous dysplasia presents early during childhood
5. McCune-Albright syndrome also manifests during early childhood.
Www.jorl.net6. Among facial bones commonest to be involved is ethmoid, followed by frontal and maxilla
3
 At present involvement of skull base is the most common feature when fibrous dysplasia involves 
craniofacial skeleton
5.
Pathophysiology:
Intramedullary lesions grossly appear as well cirucumscribed tumors varying greatly in size.  Large 
intramedullary lesions tend to cause bone expansion and distortion.
Microscopic appearance: These lesions appear as irregular trabeculae of woven immature bone. 
They resemble chinese characters.  These lesions are surrounded by normal bone and covered byr 
cellular fibrous stroma with osteoblast progenitor cells closely resembling fibroblasts.
In fibrous dysplasia bone marrow stromal cell differentiation is arrested.  This leads to proliferation 
of immature cells causing the characteristic fibrous dysplasia.
6
The exact molecular etiology causing this problem has been identified as somatic missense 
mutation involving GNAS 1 gene on chromosome 20.
7  This gene is responsible for encoding ά 
subunit of stimulatory G protein coupled receptor Gs ά.  In fibrous dysplasia cells arginine is 
replaced  by either cysteine / histidine.  This results in inhibition of intrinsic GTPase activity of Gs 
ά protein.  This causes independent activation and accumulation of Cyclic AMP.  In bone this 
causes an effect similar to that of continuous parathormone stimulation.  Growth of fibrous 
dysplasia is enhanced in the presence of growth stimulating hormones.   Growth rate of fibrous 
dysplasia decreases with age as the growth stimualting hormone levels decrease.
8
Clinical features of fibrous dysplasia:
Clinical features are largely dependent on compression of adjacent structures.
1. Asymptomatic painless bony enlargement causing deformity and asymmetry
9
2. Headahce
3. Blurring of vision 
10
4. Visual field defects 
10
5. Diplopia 
10
6. Hearing loss
7. Epiphora
8. Eyelid position abnormalities
Www.jorl.netImage showing fibrous dysplasia of right maxilla showing asymmetry of face 
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Non skeletal manifestations of Fibrous dysplasia:
11
1. Abnormal cutaneous pigmentation (Jagged “coast of Maine” border
2. Precocious puberty
3. Hyperthyroidism
4. Cushing's disease
5. Hyperparathyroidism
6. Hypophosphatemic rickets
Albright syndrome:
Also known as McCune-Albright syndrome is characterised by:
1. Precocious puberty
2. Polyostotic fibrous dysplasia
3. Cutaneous pigmentation
 
Important feature of this syndrome is that precocious puberty is seen affecting only females where 
as other endocrine anamolies tend to affect both males and females rather equally.  Almost all these 
disorders have been known to be caused by the same underlying mutation.
Role of radiology in the diagnosis of fibrous dysplasia:
Majority of fibrous dysplasia are asymptomatic but for the asymmetry caused by the lesion.  Since 
these tumors are very slow growing ones, it could take a long time before the effects of 
neurovascular compression begin to take place.  
Radiological diagnosis alone would suffice for all patients with monostotic fibrous dysplasia.  But 
polyostotic fibrous dysplastic lesions should always be biopsied for histopathological correlation.
12
Www.jorl.netCT appearance of fibrous dysplasia:
Commonly the lesion appears like ground glass – 50-60%
Homogenous dense pattern – seen in 20-30%
Cystic pattern – Seen in 10-20% of cases
CT coronal cut of nose and paranasal sinuses showing fibrous dysplasia of left maxilla.  This is the 
classic homogenous dense pattern
CT scan showing fibrous dysplasia of zygoma
This lesion is confined to the interior of the maxilla without any soft tissue component. This feature 
is very useful in distinguishing this condition from malignancy.  Malignant lesions involving 
maxilla is always associated with osteolysis, bone destruction with extension into surrounding soft 
tissues.
11
CT scan is very efficient in assessing cranial nerve / optic nerve compression.
Www.jorl.netAxial CT showing fibrous dysplasia involving poterior ethmoid cells (ground glass type) on the 
right side.  Note the lesion is seen compressing optic nerve
In studies involving skull base three dimensional reconstitution of Helical CT images will help in 
visualizing fibrous dysplasia involving skull base.
MRI:
In MRI the signal intensity on T1 and T2 weighted images depends on:
1. Amount of bone trabeculation
2. Degree of cellularity
Characteristically MRI images show low signal intensity with well defined borders both in T1 and 
T2 weighted images.  This reduction in signal intensity is due to the presence of numerous bony 
trabeculae.  Replacement of normal bone marrow tissue by fibrocellular tissue is responsible for 
signal enhancement in MRI studies
13.
Www.jorl.netMRI T1 weighted scan showing intense lesion involving posterior ethmoid cells impining on right 
optic nerve
The best imaging modality which can detect the boundaries of fibrous dysplasia involvementis 
single photon emission CT scan 
14.
Www.jorl.netMRI T1 weighted showing fibrous dysplasia involving posterior ethmoid on the right side.  The 
mass appears to have low signal intensity in the middle surrounded by peripheral enhancement. 
This enhancement has been attributed to the presence of fibrous tissue which has replaced the 
normal bone architecture in this patient.
MRI T1 weighted image showing hyperintense mass involving left zygoma.  (Fibrous dysplasia of 
zygoma)
Inclusion criteria:
All cases of fibrous dysplasia diagnosed radiologically / Histopathologically during the period
 2005 – 2010 were included in this study.
Total number of cases – 15
Maxilla – 10
Mandible – 3
Posterior ethmoid / sphenoid – 1
Zygoma – 1
Www.jorl.netChart showing the distribution pattern of fibrous dysplasia in various craniofacial bones among 15 
cases taken up for study.
Curiously all the patients presented were females.  Literature search reveals female preponderance 
only to polyostotic fibrous dysplasia.  As far as monostotic fibrous dysplasia no demonstrable 
female preponderance was reported in any literature
1.
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 Graph showing age at which these patients presented.  Majority of patients i.e. 9 presented during 
first decade of life.  Only one patient presented during the 6
th decade of life 
16.
Signs & symptoms these patients presented with include:
1. Facial asymmetry – 15
2. Mass lesion – 15
3. Loosening of teeth – 4
4. Pain – 10
5. Tenderness – 12
6. Visual disturbances – 1:  This patient had a total loss of vision.  Vison loss is commonly 
caused by progressive compression of venous drainage from the optic nerve causing reduced 
retinal perfusion 
19.
7. Proptosis – 8
8. Epiphora – 1
Chart showing the various symptoms patients with craniofacial fibrous dysplasia presented with.
None of these patients were submitted for irradiation because of the fear of sarcomatous malignant 
transformation 
17.
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deformity.
Www.jorl.netClinical photograph of a patient with fibrous dysplasia of left maxilla with proptosis and upward 
displacement of left eye.
Fullness and obliteration of bucco gingival sulcus seen in a patient with fibrous dysplasia of maxilla
In this study author was able to observe two histological types of fibrous dysplasia:
1. With increased vascular component.  Cyst formation with hemorrhagic spaces lined by 
fibroblasts and multinucleated giant cells were seen.
2. With reduced vascular component.  In these patients there was demonstrable fibroblastic 
proliferation with mature irregular bone formation.
Patients belonging to category I had brisk bleeding on the table while patients of the second 
Www.jorl.netcategory provided virtually bloodless field during surgery.  Patients with increased vascular 
components needed bone wax to stop bleeding 
19.  
Two patients in the authors study belonged to the histologic category I.  These patients had brisk 
bleeding on the table during surgery which needed bone wax occlusion.
Chen & Noordoff classification 
20 of craniofacial fibrous dysplasia:
1. Zone I : Fibrous dysplasia involving fronto orbital, zygomatic and upper portions of maxilla
2. Zone II: Fibrous dysplasia involving cranium (in its hair bearing area)
3. Zone III: Fibrous dysplasia involving the central portion of skull base
4. Zone IV: Fibrous dysplasia involving teeth bearing regions of maxilla and mandible.
This classification helps in deciding the management modality.  Optimal management modalities 
suggested by Chen & Noordoff according to their classification include:
Zone I – Total excision
Zones II, III and IV – Conservative excision
In this study 12 cases belonged to zone IV category.
One case belonged to zone III.
Two cases belonged to Zone I category
Chart showing the number of patients belonging to various  Chen & Noordoff  categories
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14Clinical photograph and CT scan image from a patient with zone IV fibrous dysplasia.
Management:
Review of literature shows a distinct lack of level I evidence regarding medical management of this 
condition.  Attempts at using biphosphonates 
21 which could inhibit osteoclastic bone resorption 
have been successful in varying degrees.  Intravenous administration of pamidronate
22 which is a 
nitrogen containing biphosphonate has been found to be successful when used for a period of more 
than two years.  It reduced pain to a large extent.  This drug was initially introduced as a 
prophylaxis against osteoporosis.  It is usually mixed with mannitol and administered intravenously 
in doses of 90 mg/month.  In children this drug can evoke abnormal increase in the bone mass 
index.  
Role of steroids 
23 in management of these patients are highly debatable.  Current opionion suggests 
that it can be used in patients with deterioration of vision in order to buy time before definitive 
decompression surgery could be performed.
Surgery:
Ideally speaking surgery should be deferred till the lesion stabilizes / till the patient grows out of 
their teens.  This wait will ensure less recurrence.
In this study two cases (ZONE I) under went complete resection, and all the other patients 
underwent curettage.  All these patients are under regular follow up since recurrence rate is rather 
high in them.
Www.jorl.netPhotograph of gross specimen from patient with complete enbloc removal of fibrous dysplasia of 
maxilla
Discussion:
After review of published literature on this subject in the absence of Level I evidence regarding the 
optimal treatment modality it has to be said that one has to go by one's own experience.  All the 
patients who reported to this author were initially managed medically with biphosphonates.  Two 
patients showed rapid increase in the bone mass index and hence drugs had to be stopped.  Surgery 
had to be resorted to in all of them because of pain / tenderness / cosmetic disfigurement.  All the 
patients in this study were females and hence pressure on cosmesis was more.  One patient with 
fibrous dysplasia of posterior ethmoids presented with blindness.  Steroids was administered in that 
patient but vision did not improve.  One patient in this study presented during 6
th decade of her life 
with fibrous dysplasia of zygoma.  
Levels of serum alkaline phosphatase was elevated in 14 out of 15 patients.  Serum levels of 
calcium was found to be raised in 3 patients.  They were actually in their early teens.
Conclusion:
This is a genetic non hereditary condition with a benign course in majority of patients.  Depending 
on its location rarely it can cause blindness.  Review of literature published reveal that there is no 
correlation between age and course of the disease.  In the absence of Level I evidence regarding the 
optimal management modality a surgeon is at a dilemma whether to operate or not.  Invariably he 
has to call on his experience to make a decision.
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